Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

KNSA 11.12.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-19
Name of Upcoming Event:2024 Jefferies London Healthcare Conference
Full Press ReleaseSEC FilingsOur KNSA Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.13.2025 - Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance
  • 01.13.2025 - Investor Presentation

Recent Filings

  • 01.15.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.13.2025 - 8-K Current report
  • 01.13.2025 - 144 Report of proposed sale of securities
PDF Version

LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) --Kiniksa Pharmaceuticals International, plc(Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 12:00 p.m. Greenwich Mean Time (7:00 a.m. Eastern Time).

A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website atwww.kiniksa.com.A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About KiniksaKiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visitwww.kiniksa.com.

Every Second Counts!®

Kiniksa Investor ContactJonathan Kirshenbaum(781) 829-3949jkirshenbaum@kiniksa.com

Kiniksa Media ContactTyler Gagnon(781) 431-9100tgagnon@kiniksa.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com